Position in DHR
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$1,333,267
-$1,007,897 QoQ
Shares Held
7,032
-31.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PROFUND ADVISORS LLC holds $17,223,778 across 18 Diagnostics & Research names. DHR ranks #6 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
6,053 | $3,401,120 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,199 | $2,063,934 | |
| 3 | TWST |
Twist Bioscience Corp
|
43,039 | $2,045,213 | |
| 4 | NTRA |
Natera, Inc.
|
10,000 | $1,999,900 | |
| 5 | VCYT |
Veracyte, Inc.
|
48,774 | $1,571,010 | |
| 6 | DHR |
Danaher Corp /De/
This page
|
7,032 | $1,333,267 | |
| 7 | GRAL |
GRAIL, Inc.
|
24,788 | $1,281,043 | |
| 8 | CDNA |
CareDx, Inc.
|
35,217 | $611,367 |
All Filings in DHR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,333,267 | 7,032 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,341,164 | 10,227 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,631,481 | 8,229 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,606,592 | 8,133 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,794,775 | 8,755 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,076,968 | 9,048 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,960,356 | 10,648 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,503,497 | 10,020 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,511,933 | 10,059 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,602,112 | 11,248 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,525,906 | 10,181 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,540,160 | 10,584 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,569,547 | 10,195 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $20,382,927 | 76,795 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $19,435,289 | 75,246 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $19,678,731 | 77,622 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $24,731,823 | 84,314 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $30,607,138 | 93,028 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,007,647 | 13,164 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,462,380 | 12,902 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,869,769 | 12,750 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,156,831 | 14,211 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $3,091,708 | 14,358 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,169,854 | 17,926 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,940,231 | 14,018 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||